2-hydroxyglutaric aciduria
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
2-hydroxyglutaric aciduria is a condition that causes progressive damage to the brain. The major types of this disorder are called D-2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA).
Video picks for Genetic conditionsVideo library
Description
2-hydroxyglutaric aciduria is a condition that causes progressive damage to the brain. The major types of this disorder are called D-2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA).
The main features of D-2-HGA are delayed development, seizures, weak muscle tone (hypotonia), and abnormalities in the largest part of the brain (the cerebrum), which controls many important functions such as muscle movement, speech, vision, thinking, emotion, and memory. Researchers have described two subtypes of D-2-HGA, type I and type II. The two subtypes are distinguished by their genetic cause and pattern of inheritance, although they also have some differences in signs and symptoms. Type II tends to begin earlier and often causes more severe health problems than type I. Type II may also be associated with a weakened and enlarged heart (cardiomyopathy), a feature that is typically not found with type I.
L-2-HGA particularly affects a region of the brain called the cerebellum, which is involved in coordinating movements. As a result, many affected individuals have problems with balance and muscle coordination (ataxia). Additional features of L-2-HGA can include delayed development, seizures, speech difficulties, and an unusually large head (macrocephaly). Typically, signs and symptoms of this disorder begin during infancy or early childhood. The disorder worsens over time, usually leading to severe disability by early adulthood.
Combined D,L-2-HGA causes severe brain abnormalities that become apparent in early infancy. Affected infants have severe seizures, weak muscle tone (hypotonia), and breathing and feeding problems. They usually survive only into infancy or early childhood.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
2-HGA
Patient picks for Genetic conditions

Diabetes Q&A
How do you get tested for type 2 diabetes?
Dr Sarah Jarvis MBE It is now recommended that the blood test for HbA1c can also be used as a test to diagnose type 2 diabetes. An HbA1c value of 48 mmol/mol (6.5%) or above is recommended as the blood level for diagnosing diabetes. In many cases type 2 diabetes is diagnosed during a routine medical or when tests are done for an unrelated medical condition. For more information on type 2 diabetes, go to [https://patient.info/health/type-2-diabetes](https://patient.info/health/type-2-diabetes)
by Dr Sarah Jarvis

Diabetes
How do you get tested for type 2 diabetes?
Dr Partha Kar A simple dipstick test may detect sugar (glucose) in a sample of urine. However, this is not sufficient to make a definite diagnosis of diabetes. Therefore, a blood test is needed to make the diagnosis. [https://patient.info/health/type-2-diabetes#nav-3](https://patient.info/health/type-2-diabetes#nav-3)

Other diabetes
What does insulin do?
Dr Partha Kar In type 1 diabetes, the body stops making insulin and the blood sugar level goes very high. Some people who have type 2 diabetes may also need to have insulin injections to help control blood sugar levels. Insulin is usually injected under the skin between 2-4 times a day. For more information on insulin, go to [https://patient.info/health/type-1-diabetes/insulins](https://patient.info/health/type-1-diabetes/insulins)
by Dr Partha Kar, FRCP

Type 2 diabetes Q&A
How do you know if you have type 2 diabetes?
Dr Partha Kar Type 2 diabetes symptoms often come on gradually and can be quite vague at first. Many people have diabetes for a long period of time before their diagnosis is made. [https://patient.info/health/type-2-diabetes#nav-2](https://patient.info/health/type-2-diabetes#nav-2)
by Dr Partha Kar, FRCP

Type 2 diabetes Q&A
How does type 2 diabetes affect your weight?
Dr Partha Kar The first-line treatment for type 2 diabetes is diet, weight control and physical activity. If the blood sugar (glucose) level remains high despite these measures then tablets to reduce the blood glucose level are usually advised. For more information on type 2 diabetes, go to [https://patient.info/health/type-2-diabetes](https://patient.info/health/type-2-diabetes)
by Dr Partha Kar, FRCP

PID Q&A
How do you contract PID?
Dr Sarah Jarvis MBE It is not known how many women develop PID each year, and it is probably often not picked up. It most commonly develops in women aged between 15 and 24 years. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Newborn bloodspot test
Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. This is the blood spot screening programme and it is also known as the heel prick test. Also, a sud... All four devolved nations of the United Kingdom now offer screening for four other serious, but.

Patient information leaflet
Immunisation for flu
The live attenuated flu vaccine comes as a nasal spray, and is given to children. Each year, the UK national flu vaccine programme gives instructions on which type of vaccine should be given to each group of people. Who is eligible for the flu jab. The Department of Health issues advice as to who should be immunised. This is reviewed each year..

Patient information leaflet
Diabetes in children
Diabetes is a lifelong condition that sometimes starts in childhood. As a result of ongoing research, our understanding of diabetes has greatly improved and there are now extensive support and treatments available for diabetes. About 9 in 10 children and young people in the UK who have diabetes will have type 1 diabetes, and 1 in 10 will have type.

Patient information leaflet
Type 2 diabetes
This is called insulin resistance. The cells in your body become resistant to normal levels of insulin. This means that you need more insulin than you normally make to keep the blood sugar (glucose) level down; or A combination of the above two reasons. You can learn more about insulin and blood glucose from our separate leaflet called Diabetes.

Patient information leaflet
Diabetes
In addition to the treatment from healthcare professionals, it is very important for people with diabetes to understand their condition and be able to manage their diabetes. ...iabetes mellitus, which are called type 1 diabetes and type 2 diabetesFind out more here:.

Patient information leaflet
Type 2 diabetes treatment
Managing type 2 diabetes Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. Regardless of whether you need medication or which medication you are taking, diet and lifestyle play a key part in preventing long-term complications. You can find out more.
Further reading and references
- 2-hydroxyglutaric aciduria; MedlinePlus, National Library of Medicine.
- Kranendijk M, Struys EA, Gibson KM, Wickenhagen WV, Abdenur JE, Buechner J, Christensen E, de Kremer RD, Errami A, Gissen P, Gradowska W, Hobson E, Islam L, Korman SH, Kurczynski T, Maranda B, Meli C, Rizzo C, Sansaricq C, Trefz FK, Webster R, Jakobs C, Salomons GS. Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria. Hum Mutat. 2010 Mar;31(3):279-83. doi: 10.1002/humu.21186.
- Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C. Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis. 2012 Jul;35(4):571-87. doi: 10.1007/s10545-012-9462-5. Epub 2012 Mar 6.
- Kranendijk M, Struys EA, van Schaftingen E, Gibson KM, Kanhai WA, van der Knaap MS, Amiel J, Buist NR, Das AM, de Klerk JB, Feigenbaum AS, Grange DK, Hofstede FC, Holme E, Kirk EP, Korman SH, Morava E, Morris A, Smeitink J, Sukhai RN, Vallance H, Jakobs C, Salomons GS. IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science. 2010 Oct 15;330(6002):336. doi: 10.1126/science.1192632. Epub 2010 Sep 16.
- Muntau AC, Roschinger W, Merkenschlager A, van der Knaap MS, Jakobs C, Duran M, Hoffmann GF, Roscher AA. Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria? Neuropediatrics. 2000 Jun;31(3):137-40. doi: 10.1055/s-2000-7497.
- Nota B, Struys EA, Pop A, Jansen EE, Fernandez Ojeda MR, Kanhai WA, Kranendijk M, van Dooren SJ, Bevova MR, Sistermans EA, Nieuwint AW, Barth M, Ben-Omran T, Hoffmann GF, de Lonlay P, McDonald MT, Meberg A, Muntau AC, Nuoffer JM, Parini R, Read MH, Renneberg A, Santer R, Strahleck T, van Schaftingen E, van der Knaap MS, Jakobs C, Salomons GS. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet. 2013 Apr 4;92(4):627-31. doi: 10.1016/j.ajhg.2013.03.009.
- Rzem R, Veiga-da-Cunha M, Noel G, Goffette S, Nassogne MC, Tabarki B, Scholler C, Marquardt T, Vikkula M, Van Schaftingen E. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16849-54. doi: 10.1073/pnas.0404840101. Epub 2004 Nov 17.
- Struys EA, Salomons GS, Achouri Y, Van Schaftingen E, Grosso S, Craigen WJ, Verhoeven NM, Jakobs C. Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am J Hum Genet. 2005 Feb;76(2):358-60. doi: 10.1086/427890. Epub 2004 Dec 17.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

